These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33556418)

  • 1. Assessment of the toxicity and toxicokinetics of the novel potent tropomyosin receptor kinase (Trk) inhibitor LPM4870108 in rhesus monkeys.
    Duan S; Dong L; Wang B; Wei S; Gong X; Yu P; Li C; Gao Y; Ye L; Wang H; Tian J
    Regul Toxicol Pharmacol; 2021 Jun; 122():104886. PubMed ID: 33556418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of toxicity and toxicokinetics/pharmacokinetics of an alpha 1L-adrenoceptor agonist in rats and rhesus monkeys.
    Matsumaru T; Sugiura R; Sakai K; Igarashi T; Kuno T
    J Pharmacol Sci; 2005 Feb; 97(2):273-83. PubMed ID: 15699575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrosine kinase inhibitor LPM4870108 impairs learning and memory and induces transcriptomic and gene‑specific DNA methylation changes in rats.
    Duan S; Li C; Gao Y; Meng P; Ji S; Xu Y; Mao Y; Wang H; Tian J
    Arch Toxicol; 2022 Mar; 96(3):845-857. PubMed ID: 35098321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety evaluation of recombinant staphylokinase in rhesus monkeys.
    Lu Q; Li Y; Wen L; Guo S; Chen Y; Liu W; Gao Y; Ding L
    Toxicol Pathol; 2003; 31(1):14-21. PubMed ID: 12597445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors.
    Aristizabal Prada ET; Heinzle V; Knösel T; Nölting S; Spöttl G; Maurer J; Spitzweg C; Angele M; Schmidt N; Beuschlein F; Stalla GK; Blaser R; Kuhn KA; Auernhammer CJ
    Endocr Relat Cancer; 2018 May; 25(5):547-560. PubMed ID: 29563190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys.
    Guo L; Geng X; Chen Y; Qi F; Liu L; Miao Y; Lin Z; Yu M; Li Z; Fu Y; Li B; Luo Y
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):512-23. PubMed ID: 24878240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel in-cell ELISA method for screening of compounds inhibiting TRKA phosphorylation, using KM12 cell line harboring TRKA rearrangement.
    Pandre MK; Shaik S; Satya Pratap VVV; Yadlapalli P; Yanamandra M; Mitra S
    Anal Biochem; 2018 Mar; 545():78-83. PubMed ID: 29360440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity assessment of pramipexole in juvenile rhesus monkeys.
    Patterson TA; Li M; Hotchkiss CE; Mauz A; Eddie M; Greischel A; Stierstorfer B; Deschl U; Paule MG
    Toxicology; 2010 Oct; 276(3):164-71. PubMed ID: 20705114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part I.
    Bailey JJ; Schirrmacher R; Farrell K; Bernard-Gauthier V
    Expert Opin Ther Pat; 2017 Jun; 27(6):733-751. PubMed ID: 28270010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GMP-grade α-TEA lysine salt: a 28-Day oral toxicity and toxicokinetic study with a 28-Day recovery period in Beagle dogs.
    Guerrouahen BS; Hahn T; Alderman Z; Curti B; Urba W; Akporiaye ET
    BMC Cancer; 2016 Mar; 16():199. PubMed ID: 26957307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subchronic toxicity and concomitant toxicokinetics of long-term oral administration of total alkaloid extracts from seeds of Peganum harmala Linn: A 28-day study in rats.
    Wang Y; Wang H; Zhang L; Zhang Y; Sheng Y; Deng G; Li S; Cao N; Guan H; Cheng X; Wang C
    J Ethnopharmacol; 2019 Jun; 238():111866. PubMed ID: 30970283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.
    Laetsch TW; DuBois SG; Mascarenhas L; Turpin B; Federman N; Albert CM; Nagasubramanian R; Davis JL; Rudzinski E; Feraco AM; Tuch BB; Ebata KT; Reynolds M; Smith S; Cruickshank S; Cox MC; Pappo AS; Hawkins DS
    Lancet Oncol; 2018 May; 19(5):705-714. PubMed ID: 29606586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year inhalation toxicity study of chlorine in rhesus monkeys (Macaca mulatta).
    Klonne DR; Ulrich CE; Riley MG; Hamm TE; Morgan KT; Barrow CS
    Fundam Appl Toxicol; 1987 Oct; 9(3):557-72. PubMed ID: 3692014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway.
    Thress K; Macintyre T; Wang H; Whitston D; Liu ZY; Hoffmann E; Wang T; Brown JL; Webster K; Omer C; Zage PE; Zeng L; Zweidler-McKay PA
    Mol Cancer Ther; 2009 Jul; 8(7):1818-27. PubMed ID: 19509272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and toxicokinetics of the cyclin-dependent kinase inhibitor AG-024322 in cynomolgus monkeys following intravenous infusion.
    Brown AP; Courtney CL; Criswell KA; Holliman CL; Evering W; Jessen BA
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1091-101. PubMed ID: 18509643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of on-target adverse events caused by TRK inhibitor therapy.
    Liu D; Flory J; Lin A; Offin M; Falcon CJ; Murciano-Goroff YR; Rosen E; Guo R; Basu E; Li BT; Harding JJ; Iyer G; Jhaveri K; Gounder MM; Shukla NN; Roberts SS; Glade-Bender J; Kaplanis L; Schram A; Hyman DM; Drilon A
    Ann Oncol; 2020 Sep; 31(9):1207-1215. PubMed ID: 32422171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A safety study of a novel photosensitizer, sinoporphyrin sodium, for photodynamic therapy in Beagle dogs.
    Lin N; Li C; Wang Z; Zhang J; Ye X; Gao W; Wang A; Jin H; Wei J
    Photochem Photobiol Sci; 2015 Apr; 14(4):815-32. PubMed ID: 25671327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety evaluation of fluvastatin, an HMG-CoA reductase inhibitor, in beagle dogs and rhesus monkeys.
    Hartman HA; Myers LA; Evans M; Robison RL; Engstrom RG; Tse FL
    Fundam Appl Toxicol; 1996 Jan; 29(1):48-62. PubMed ID: 8838639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and toxicokinetics assessment of the mono-PEGylated recombinant human interleukin-11 in cynomolgus monkeys.
    Li X; Pang PS; Zhang S; Ru L; Yuan Z; Liu R; Choo QL; Wang Q; Song J; Xu Q; Zhang K; Yu KM; Xu Z
    Life Sci; 2020 Oct; 259():118244. PubMed ID: 32791145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and Structure-Activity Relationships (SAR) of 3-vinylindazole derivatives as new selective tropomyosin receptor kinases (Trk) inhibitors.
    Duan Y; Wang J; Zhu S; Tu ZC; Zhang Z; Chan S; Ding K
    Eur J Med Chem; 2020 Oct; 203():112552. PubMed ID: 32702585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.